{Reference Type}: Journal Article
{Title}: East meets West: Bringing the ESH 2023 hypertension guidelines into Asia.
{Author}: Sukonthasarn A;Borghi C;Chan YH;Cheng F;Choi HI;Mehta R;Le B;Lim IH;Lin TH;Rosman A;Tiksnadi BB;Manolis A;
{Journal}: Eur J Intern Med
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 2
{Factor}: 7.749
{DOI}: 10.1016/j.ejim.2024.06.026
{Abstract}: Hypertension remains a major problem worldwide, especially across the Asia-Pacific region, which reports high prevalence rates and slow improvements in treatment rate and blood pressure (BP) control rate. Asian patients with hypertension may also vary with regard to phenotype and the epidemiology of the complications of hypertension, especially when compared with Western patients. Given these differences, Western guidelines may not necessarily be applicable to countries in the Asia Pacific. This narrative review aims to provide a critical comparison between the recently published European Society of Hypertension (ESH) 2023 guidelines and existing local guidelines in select Asian countries, offer expert opinion on how to fill gaps in the ESH 2023 guidelines for hypertension in the Asian context, and examine the need for harmonisation of hypertension guidelines worldwide. This review focuses on the definition and diagnosis of hypertension, the treatment thresholds and targets, and recommendations on the use of pharmacotherapy.